NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks hyperopia.
It is speculative as to why additional space has been leased, as there has been no official announcement from Northwest Biotherapeutics yet, but the space at Unity Campus seems primarily intended for R&D and product development, not leukapheresis, IMO. Given the recent collaboration with private clinics for leukapheresis, it seems more likely that blood collection will take place there, while cell processing and DCVax-L production will likely occur at the Sawston facility.

It appears that Northwest Biotherapeutics and Advent Bioservices have each leased separate parts of the ground floor of the Cadence building on the Unity Campus, though it is not yet known which tenant occupies which side (East or West). The Cadence building offers a total of 30,082 sq ft of fully fitted laboratory and office space, designed to foster innovation.

The available ground floor spaces are as follows:

Ground Floor East (4,120 sq ft) with 37 labstations and 26 workstations (total of 63 stations).

Ground Floor West (4,312 sq ft) with 33 labstations and 26 workstations (total of 59 stations).


Both suites offer the flexibility of being leased separately or together. These spaces are equipped to support life sciences and R&D activities, with labstations greater than 1,500mm.

In addition, ViaNautis, a ground-breaking nanomedicine company focused on genetic therapies, signed a 10-year lease last year for 10,825 sq ft of first floor laboratory, write-up, and office space within the Cadence building.